Delivery Order SPE2DB20D3103-SPE2DB21FP8Y4

Award Date 8/16/21
Potential Completion Date 8/17/21
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,265.30 delivery order is for the provision of Mucinex D ER 600-60 mg tablets, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of December 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA...
This federal contract award, valued at $1,581.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora holds with the DLA, valued at up to $999,999,999.00 and running through December 2025. The contract is for the delivery of 4,556,025,931 units of Mucinex D ER 600-60 mg tablets. This pharmaceutical product is likely being supplied to support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $7,395.99 firm-fixed-price delivery order is for Mucinex D ER 600-60 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This single-award IDC serves as the primary vehicle for Cencora, Inc. to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Mucinex ER 600 mg tablets. The total ceiling value of the contract is $1,840.50, with a period of performance through April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
This federal contract award, identified as SPE2DX15D3007|SPE2DX23F9P9J, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,639.22 delivery order covers the supply of 4562316336 - Mucinex D ER 600-60 MG Tablet 36s. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
This federal contract award, valued at $1,386.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Mucinex ER 600 mg tablets in quantities of 20s and has a completion date of February 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,925.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract covers the delivery of Mucinex D ER 600-60 mg tablets, a pharmaceutical product used for medical treatment. This award is not designated with a...
This federal contract award is for the delivery of Mucinex D ER 600-60 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract, valued at $1,081.53, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of October 25, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support...
This federal contract award, valued at $2,904.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Mucinex D ER 600-60 mg tablets, a pharmaceutical product, with a completion date of February 26, 2024. The contract type is a Delivery Order under a Firm Fixed Price pricing structure. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,059.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Mucinex D ER 600-60 MG Tablet 36S, a pharmaceutical product. The award is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FP8Y4
    Delivery Order

This federal contract award is held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, with a ceiling value of $1,355.54, was awarded by the Defense Logistics Agency (DLA) for the delivery of Mucinex D ER 600-60 mg tablets. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Cencora, Inc. and its subsidiaries play a critical role in supplying pharmaceutical products and medical supplies to support the healthcare needs of the U.S. Department of Defense and Department of Veterans Affairs.

Generated 2/27/25, 12:31 PM